Ketamine Therapy and Pregnancy: What Women Need to Know

One of the most important conversations I have with patients of childbearing age involves planning. When ketamine therapy is helping you feel better --- sometimes dramatically better --- the question of what happens when you want to start a family carries real weight. You do not want to lose the mental health gains you have worked so hard to achieve, but you also want to protect your future child.

I want to be direct about this: ketamine therapy is contraindicated during pregnancy and while breastfeeding. This is not a gray area. But understanding the reasons behind this guidance, knowing when and how to plan for discontinuation, and having a clear picture of what alternatives exist can help you navigate this transition with confidence.

Why Ketamine Is Contraindicated During Pregnancy

Ketamine crosses the placental barrier, meaning that when a pregnant person takes ketamine, the developing fetus is exposed to the drug as well. Animal studies have raised concerns about the potential effects of ketamine on fetal neurodevelopment, particularly during critical periods of brain formation.

The NMDA receptors that ketamine modulates play essential roles in normal brain development. During fetal development, glutamate signaling through NMDA receptors guides the formation of neural connections, the migration of neurons to their correct positions, and the establishment of the synaptic architecture that will support cognition and behavior throughout life. Blocking these receptors during development could interfere with these processes.

While human data is limited --- for obvious ethical reasons, no controlled studies expose pregnant women to ketamine --- the precautionary principle demands that we avoid any substance with the potential to disrupt fetal neurodevelopment. This is consistent with guidance across the medical community regarding NMDA receptor antagonists during pregnancy.

Additionally, ketamine can affect uterine blood flow and has been associated with changes in uterine tone. These effects, while well-managed in surgical settings, add another reason for caution during pregnancy.

For a fuller picture of how we assess patient safety, visit our ketamine safety page.

When to Stop Ketamine Before Conceiving

If you are currently receiving ketamine therapy and are thinking about becoming pregnant, the best time to have this conversation is before you start trying to conceive. I recommend the following approach.

Begin the conversation early. Ideally, bring up your family planning goals at least three to six months before you intend to start trying. This gives us time to develop a comprehensive transition plan that protects both your mental health and your future pregnancy.

Taper rather than stop abruptly. While ketamine does not cause the same kind of physical dependence as opioids or benzodiazepines, abruptly stopping treatment can lead to a return of depressive symptoms. A gradual taper, combined with the introduction of pregnancy-safe mood support, gives your brain time to maintain the neuroplastic gains you have achieved during treatment.

Establish alternative support. Before discontinuing ketamine, we work together to ensure you have robust alternative strategies in place. This may include therapy, pregnancy-safe medications, lifestyle modifications, and a monitoring plan to catch any mood deterioration early.

Allow a washout period. Ketamine is metabolized relatively quickly, with the drug itself cleared from the body within hours. However, I recommend allowing at least two to four weeks after your last dose before actively trying to conceive. This provides a comfortable margin of safety.

Understanding what to expect when adjusting your treatment helps reduce anxiety about the transition.

Managing Mental Health During Pregnancy

Discontinuing a treatment that has been working well is understandably anxiety-provoking. Many patients worry that their depression will return with full force once they stop ketamine. While this is a valid concern, there are several important points to keep in mind.

Ketamine promotes lasting changes. Unlike medications that only work while you are taking them, ketamine therapy promotes structural neuroplastic changes --- the growth of new synaptic connections. These changes do not disappear immediately when treatment stops. Many patients find that the improvements they experienced during treatment persist for weeks to months after their last dose, particularly if they have completed a full course of treatment.

Pregnancy-safe options exist. Several antidepressants have well-established safety profiles during pregnancy. SSRIs such as sertraline have been used extensively in pregnant patients, and the risks and benefits are well understood. Your psychiatrist or prescribing physician can help you find the right option for your specific situation.

Therapy is especially valuable during this time. Cognitive behavioral therapy, interpersonal therapy, and other evidence-based psychotherapy approaches are both safe and effective during pregnancy. If you are not already in therapy, the pre-conception period is an excellent time to establish a therapeutic relationship that can support you through pregnancy and the postpartum period.

Monitoring matters. We create a clear plan for monitoring your mood during pregnancy, with specific check-in points and criteria for escalating care if needed. You should never feel like you are navigating this alone.

Postpartum Depression: What Are the Options?

Postpartum depression affects approximately one in seven women and can range from mild to severely debilitating. For patients who responded well to ketamine therapy before pregnancy, it is natural to wonder whether ketamine can be resumed after delivery.

If you are not breastfeeding, ketamine therapy can typically be resumed after delivery once you have been medically cleared. The timeline depends on your mode of delivery and overall recovery, but many patients can restart treatment within a few weeks of giving birth.

If you are breastfeeding, ketamine remains contraindicated. Ketamine and its metabolites can pass into breast milk, and the effects on a nursing infant are not well studied. The same concerns about NMDA receptor modulation in the developing brain apply, as the infant brain continues to undergo rapid development throughout the first year of life.

This does not mean you are without options during the breastfeeding period. In addition to the pregnancy-safe antidepressants mentioned above, brexanolone (Zulresso) is an FDA-approved treatment specifically for postpartum depression. While it requires IV administration in a clinical setting, it represents a significant advance in treating this condition. Zuranolone (Zurzuvae) is an oral option that has also received FDA approval for postpartum depression.

For patients with severe postpartum depression who are considering stopping breastfeeding in order to resume ketamine therapy, this is a deeply personal decision that involves weighing the benefits of breastfeeding against the benefits of effective mental health treatment. There is no universal right answer, and I support patients in making the choice that is best for their family.

Planning Your Return to Ketamine Therapy

For patients who plan to resume ketamine therapy after pregnancy and breastfeeding, it helps to know what the re-entry process looks like.

In most cases, patients do not need to start completely from scratch. If you responded well to a specific dose and schedule before pregnancy, that information guides our approach when restarting treatment. We may begin at a slightly lower dose and titrate up, but the overall process is typically faster than the initial treatment course.

The neuroplastic changes from your earlier treatment may provide some residual benefit, meaning that you may respond more quickly the second time around. This is not guaranteed, but it is a pattern I have observed in practice.

Review our treatment cost information to plan for resuming therapy when the time is right.

A Note on Unplanned Pregnancies

If you discover that you are pregnant while currently receiving ketamine therapy, stop taking ketamine immediately and contact our medical team. While early exposure is concerning, a single dose or brief exposure in the very early stages of pregnancy does not automatically mean harm has occurred. Your obstetrician can provide appropriate monitoring and reassurance based on the specific timing and extent of exposure.

Do not let fear or guilt prevent you from seeking prenatal care. The most important thing you can do is communicate openly with both your mental health provider and your obstetrician so that they can coordinate your care effectively.

Your Mental Health Matters at Every Stage

Pregnancy and the postpartum period are times of enormous physical and emotional change. Having a history of depression or anxiety does not disqualify you from a healthy pregnancy --- it simply means that you need a thoughtful, proactive plan for managing your mental health throughout the process.

If you are currently considering ketamine therapy and are also thinking about starting a family in the future, that is useful information to share during your initial evaluation. Understanding how ketamine works and building a treatment timeline that accounts for your family planning goals ensures that you get the maximum benefit from treatment while keeping future doors open.

If you are ready to explore whether ketamine therapy fits into your current life stage, check your eligibility to start a conversation with our medical team. We are here to help you plan treatment that works for your whole life, not just the present moment.